Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis

Published:2020-08-31 Issue:9 Volume:18 Page:2296-2307
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Speed Victoria¹²^ORCID,Green Bruce³,Roberts Lara N.¹^ORCID,Woolcombe Sarah⁴,Bartoli‐Abdou John¹^ORCID,Barsam Sarah¹,Byrne Rosalind¹,Gee Emma¹,Czuprynska Julia¹^ORCID,Brown Alison¹,Duffy Sinead¹,Vadher Bipin¹,Patel Rachna¹,Scott Valerie¹,Gazes Anna¹,Patel Raj K.¹,Arya Roopen¹,Patel Jignesh P.¹²^ORCID

Affiliation:

1. King's Thrombosis Centre Department of Haematological Medicine King's College Hospital NHS Foundation Trust London UK

2. Institute of Pharmaceutical Science King's College London London UK

3. Model Answers R&D Brisbane QLD Australia

4. Department of Oral Surgery King's College Hospital NHS Foundation Trust London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14948

Reference45 articles.

1. Trends in the prescription of novel oral anticoagulants in UK primary care

2. The Changing Landscape for Stroke Prevention in AF

3. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

4. Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

5. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK);Clinical and Translational Science;2024-06

2. A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban;Annals of Hematology;2024-05-07

3. Oral Anticoagulants Beyond Warfarin;Annual Review of Pharmacology and Toxicology;2024-01-23

4. Direct oral anticoagulants and the risk of adverse clinical outcomes among patients with different body weight categories: a large hospital-based study;European Journal of Clinical Pharmacology;2023-11-18

5. The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development;The Journal of Clinical Pharmacology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3